Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?
about
AJRCCM: 100-Year Anniversary. Progress along the Pathway of Discovery Leading to Treatment and Cure of Cystic Fibrosis.Preserving Lung Function: The Holy Grail in Managing Cystic Fibrosis.TGFβ as a therapeutic target in cystic fibrosis.Early diagnosis from newborn screening maximises survival in severe cystic fibrosis.
P2860
Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Early Lung Disease in Infants ...... nd What Should We Do about It?
@en
type
label
Early Lung Disease in Infants ...... nd What Should We Do about It?
@en
prefLabel
Early Lung Disease in Infants ...... nd What Should We Do about It?
@en
P2093
P2860
P50
P1476
Early Lung Disease in Infants ...... nd What Should We Do about It?
@en
P2093
Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF)
Sarath C Ranganathan
Tonia A Douglas
P2860
P304
P356
10.1164/RCCM.201606-1107CI
P407
P577
2016-12-02T00:00:00Z